Mobility Energy and Transportation
Praxis Logo
Praxis Logo

India needs China for critical medicine ingredients, but an ambitious initiative aims to correct that

Know more→
Mobility Energy and Transportation

Healthcare and Lifesciences

India needs china for critical medicine ingredients, but an ambitious initiative aims to correct that

14 Aug 2022

1 min read
Despite being the third-largest manufacturer of medicines by volume, India relies on China to supply almost 70 per cent of active pharmaceutical ingredients (APIs) – chemicals that are responsible for the therapeutic effect of those medicines – such as paracetamol for painkillers

Disclaimer: The text, images and content here have been reproduced from the original publisher. Praxian Global Private Limited does not claim any ownership or right to use of this content and the rights belong to the publisher. We have contributed our perspectives, which are often proprietary, to the content publisher. We or the publisher have no obligation to update or refresh the content or our perspectives shared herein.

Ready to talk?

I want to talk to your experts in:

We work with ambitious leaders and transformative clients who are defining the future. Together, we achieve extraordinary outcomes.

India needs China for critical medicine ingredients, but an ambitious initiative aims to correct that | PraxisGA